The positive correlation between amphiregulin and insulin resistance

The positive correlation between amphiregulin and insulin resistance

Objective: Obesity and insulin resistance carry a high risk of progressing to type 2 diabetes mellitus. A lot of evidence has tightly associated insulin resistance with chronic inflammation. Besides, it has been reported that the activation of amphiregulin epidermal growth factor receptor pathways i...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yun Zhao, Ting Lu, Mian Wu, Xingna Hu, Rong Xiang, Min Feng, Honghong Lu
Format:	Article
Language:	English
Published:	Bioscientifica 2025-03-01
Series:	Endocrine Connections
Subjects:	amphiregulin insulin resistance type 2 diabetes mellitus obesity
Online Access:	https://ec.bioscientifica.com/view/journals/ec/14/4/EC-24-0580.xml
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Treg and intestinal myofibroblasts-derived Amphiregulin induced by TGF-β mediates intestinal fibrosis in Crohn’s disease
by: Lu Wang, et al.
Published: (2025-04-01)

Amphiregulin Promotes Proliferation and Migration of the Damaged Endothelial Cells in Kawasaki Disease Cell Models
by: Jiawen Xu, et al.
Published: (2025-07-01)

Interaction of fetuin-A with obesity related insulin resistance and diabetes mellitus
by: Öner-İyidoğan Yıldız, et al.
Published: (2024-12-01)

Genetic markers of insulin resistance in gestational diabetes
by: Tatiana Vasil'evna Sebko, et al.
Published: (2009-12-01)

Diabetes mellitus associated with type A insulin resistance
by: E. A. Sechko, et al.
Published: (2023-07-01)

Insulin Resistance in Type 2 Diabetes Mellitus: Pattern, Determinants, and Correlates in a Resource-Challenge Nigerian Setting
by: Oluwabukola Ayodele Ala, et al.
Published: (2024-07-01)

Data-driven cluster analysis on the association of aging, obesity and insulin resistance with new-onset diabetes in Chinese adults: a multicenter retrospective cohort study
by: Yazhi Wang, et al.
Published: (2025-07-01)

A review of insulin and insulin regimens in type 2 diabetes
by: S. Joshi, et al.
Published: (2009-04-01)

Correlation of anti-oxidant and pro-oxidant enzymes with insulin resistance in diabetic nephropathy
by: Turky Alamri, et al.
Published: (2025-01-01)

Association of BMI and WC for insulin resistance and type 2 diabetes among Brazilian adolescents
by: Cesar Pirajá Bandeira, et al.
Published: (2025-01-01)

The effects of two-week program of individually measured physical activity on insulin resistance in obese non-insulin-dependent diabetes mellitus
by: Čizmić Milica, et al.
Published: (2003-01-01)

Features of insulin therapy in combination of long-term type 1 diabetes mellitus and metabolic syndrome
by: M. D. Samsonova, et al.
Published: (2024-11-01)

Comparison of Serum Apelin-36 and Insulin Resistance between Male and Female Type 2 Diabetics
by: Maryam Moayad Mohammed, et al.
Published: (2025-04-01)

Recombinant Irisin Ameliorates Insulin Resistance in Type 2 Diabetic Mice
by: Sana Akram, et al.
Published: (2025-03-01)

Recombinant Irisin Ameliorates Insulin Resistance in Type 2 Diabetic Mice
by: Sana Akram, et al.
Published: (2025-03-01)

Recombinant Irisin Ameliorates Insulin Resistance in Type 2 Diabetic Mice
by: Sana Akram, et al.
Published: (2025-03-01)

Contributions of Hepatic Insulin Resistance and Islet β-Cell Dysfunction to the Blood Glucose Spectrum in Newly Diagnosed Type 2 Diabetes Mellitus
by: Mengge Yang, et al.
Published: (2025-07-01)

Nonalcoholic fatty liver disease: cause or consequence of insulin resistance?
by: Ekaterina E. Mishina, et al.
Published: (2017-12-01)

Association of insulin resistance and non-alcoholic fatty liver disease
by: Ekaterina E. Mishina, et al.
Published: (2021-01-01)

Association of predicted basal metabolic rate and insulin resistance in a Chinese general population
by: Linghuan Wang, et al.
Published: (2025-07-01)

Molecular Mechanisms of Insulin Resistance Development
by: Vsevolod Arsen'evich Tkachuk, et al.
Published: (2014-07-01)

From fat to facts: the potential of adipokine and insulin dosing in obese feline patients
by: Laura Cernat, et al.
Published: (2025-08-01)

LPS-induced extracellular AREG triggers macrophage pyroptosis through the EGFR/TLR4 signaling pathway
by: Gang Yuan, et al.
Published: (2025-04-01)

The interactions between inflammation and insulin resistance: molecular mechanisms in insulin-producing and insulin-dependent tissues
by: A. D. Yudaeva, et al.
Published: (2023-02-01)

Experimental cell models of insulin resistance: overview and appraisal
by: Ying Yang, et al.
Published: (2024-12-01)

Susceptibility to oxidative stress, insulin resistance, and insulin secretory response in the development of diabetes from obesity
by: Kocić Radivoj, et al.
Published: (2007-01-01)

Effects of metformin on body weight in patients with type 2 diabetes mellitus,receiving insulin analogue treatment
by: Tatiana Ivanovna Romantsova, et al.
Published: (2013-03-01)

IRISIN, OBESITY AND TYPE II DIABETES MELLITUS
by: Zainab Fathi, et al.
Published: (2025-03-01)

Overcoming marked insulin resistance in a patient with type 2 diabetes mellitus by means of insulin pumptherapy
by: Ekaterina Viktorovna Artemova, et al.
Published: (2012-09-01)

FGF21 gene therapy as treatment for obesity and insulin resistance
by: Veronica Jimenez, et al.
Published: (2018-07-01)

GLYCEMIA CONTROL, INSULIN RESISTANCE, AND FUNCTIONAL ACTIVITY OF T-HELPER SUBPOPULATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
by: I. V. Kologrivova, et al.
Published: (2014-03-01)

Insulin/weight ratio may serve as a predictor of success during insulin pump therapy in type 2 diabetes patients: a proof-of-concept study
by: Shmuel Levit, et al.
Published: (2015-03-01)

When basal insulin is not enough: successful strategies for insulin intensification in patients with type 2 diabetes mellitus
by: Elena V. Buryukova, et al.
Published: (2017-12-01)

Is the insulin necessary for the struggle against oxidative stress in diabetes mellitus type 2: A pilot study
by: Salatić Igor, et al.
Published: (2022-01-01)

CLINICAL AND ECONOMIC BENEFITS OF HUMAN INSULIN ANALOGUESUSE
by: E. E. Arinina, et al.
Published: (2015-03-01)

Circulating BCKAs are closely associated with adipose tissue insulin resistance in type 2 diabetes
by: Jie Gao, et al.
Published: (2025-08-01)

Comparison between basal insulin glargine and NPH insulin in patients with diabetes type 1 on conventional intensive insulin therapy
by: Pešić Milica, et al.
Published: (2007-01-01)

An evaluation of insulin therapy initiation among patients with type 2 diabetes attending a public health facility in South Africa
by: L. Mayet, et al.
Published: (2012-12-01)

Individual stepwise intensification of insulin analogue therapy in type 2 diabetes mellitus
by: Alexander Sergeevich Ametov, et al.
Published: (2012-12-01)

Can simple intensification of therapy with modern two-phase insulin help in type 2 diabetes when target glycemia failed to be achieved withbasal insulin? Results of subanalysis in the PRESENT study
by: Ch S Yang, et al.
Published: (2009-09-01)